Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Literature
1.
2.
Eisenhut M (2014) Vasospasm in cerebral inflammation. Int J Inflam 2014(509707):14
3.
Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P (1989) Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir 100:12–24CrossRefPubMed
4.
5.
Headache classification committee of the international headache society (IHS) (2013) The international classification of headache disorders, 3rd edn (beta version). Cephalalgia 33:1–808CrossRef
6.
Robbins MS, Grosberg BM, Napchan U, Crystal SC, Lipton RB (2010) Clinical and prognostic subforms of new daily-persistent headache. Neurology 74:1358–1364CrossRefPubMedPubMedCentral
7.
Rozen TD, Beams JL (2013) New daily persistent headache with a thunderclap headache onset and complete response to Nimodipine (A new distinct subtype of NDPH). J Headache Pain 14:100CrossRefPubMedPubMedCentral
8.
Rozen T, Swidan SZ (2007) Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine. Headache 47:1050–1055CrossRefPubMed
Metadata
Title
Chronic headache with vasospasm treated with nimodipine
Authors
Daniela Pimenta Silva
Maria Fátima Soares
Vanessa Almeida
Ana Catarina Fonseca
Publication date
01-06-2019
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 6/2019
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09287-z

Other articles of this Issue 6/2019

Journal of Neurology 6/2019 Go to the issue

Original Communication

Congenital myopathies are mainly associated with a mild cardiac phenotype

Pioneers in Neurology

Gerald M. Edelman (1929–2014)

Letter to the Editors

Acute posterior multifocal placoid pigment epitheliopathy after alemtuzumab treatment for relapsing–remitting multiple sclerosis

Original Communication

Sustained attention failures on a 3-min reaction time task is a sensitive marker of dementia

Original Communication

Clinical presentation of Moyamoya angiopathy in Europeans: experiences from Germany with 200 patients

Original Communication

Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis